Memphasys Ltd (MEM) - Total Liabilities

Latest as of December 2025: AU$6.43 Million AUD ≈ $4.55 Million USD

Based on the latest financial reports, Memphasys Ltd (MEM) has total liabilities worth AU$6.43 Million AUD (≈ $4.55 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Memphasys Ltd cash conversion from operations to assess how effectively this company generates cash.

Memphasys Ltd - Total Liabilities Trend (2007–2025)

This chart illustrates how Memphasys Ltd's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Memphasys Ltd to evaluate the company's liquid asset resilience ratio.

Memphasys Ltd Competitors by Total Liabilities

The table below lists competitors of Memphasys Ltd ranked by their total liabilities.

Company Country Total Liabilities
Radiant Utama Interinsco Tbk
JK:RUIS
Indonesia Rp710.69 Billion
Globe Kita Terang Tbk PT
JK:GLOB
Indonesia Rp1.10 Trillion
Edinburgh Worldwide Investment Trust plc
LSE:EWI
UK GBX57.63 Million
Metalsgrove Mining Ltd
AU:MGA
Australia AU$123.69K
Priceworth International Bhd
KLSE:7123
Malaysia RM149.37 Million
Trencor
JSE:TRE
South Africa ZAC5.00 Million
Asmallworld AG
SW:ASWN
Switzerland CHF7.32 Million
Adcore Inc
TO:ADCO
Canada CA$8.23 Million

Liability Composition Analysis (2007–2025)

This chart breaks down Memphasys Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Memphasys Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.14 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.60 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.62 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Memphasys Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Memphasys Ltd (2007–2025)

The table below shows the annual total liabilities of Memphasys Ltd from 2007 to 2025.

Year Total Liabilities Change
2025-06-30 AU$5.65 Million
≈ $4.00 Million
+1.10%
2024-06-30 AU$5.59 Million
≈ $3.96 Million
-23.21%
2023-06-30 AU$7.28 Million
≈ $5.15 Million
+12.49%
2022-06-30 AU$6.47 Million
≈ $4.58 Million
+8.38%
2021-06-30 AU$5.97 Million
≈ $4.23 Million
+287.19%
2020-06-30 AU$1.54 Million
≈ $1.09 Million
+101.68%
2019-06-30 AU$765.00K
≈ $541.28K
-11.62%
2018-06-30 AU$865.59K
≈ $612.46K
-88.76%
2017-06-30 AU$7.70 Million
≈ $5.45 Million
+34.76%
2016-06-30 AU$5.72 Million
≈ $4.05 Million
-6.25%
2015-06-30 AU$6.10 Million
≈ $4.31 Million
-24.67%
2014-06-30 AU$8.10 Million
≈ $5.73 Million
+21.88%
2013-06-30 AU$6.64 Million
≈ $4.70 Million
+51.31%
2012-06-30 AU$4.39 Million
≈ $3.11 Million
+22.74%
2011-06-30 AU$3.58 Million
≈ $2.53 Million
-26.63%
2010-06-30 AU$4.87 Million
≈ $3.45 Million
-20.81%
2009-06-30 AU$6.16 Million
≈ $4.36 Million
+55.65%
2008-06-30 AU$3.95 Million
≈ $2.80 Million
+48.50%
2007-06-30 AU$2.66 Million
≈ $1.88 Million
--

About Memphasys Ltd

AU:MEM Australia Medical Devices
Market Cap
$10.07 Million
AU$14.24 Million AUD
Market Cap Rank
#26845 Global
#1334 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.00 - AU$0.01
All Time High
AU$0.37
About

Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company offers Felix system, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes. It also provides RoXsta, a rapid in vitro antioxidant assessment; and AI-Port… Read more